Confidently prescribe CRENESSITY knowing your patients have access to dedicated support, like insurance verification and help enrolling in financial support programs,* when they need it, no matter their circumstances.
FINANCIAL SUPPORT
9 out of 10 people taking CRENESSITY pay $10 or less per month for their copay.
Most pay $01,*
*Additional terms and conditions apply.
Neurocrine Access Support offers the following options for financial assistance:
CRENESSITY Savings Program
Patients can pay $0 out of pocket for CRENESSITY.
The CRENESSITY Savings Program is available for patients with commercial insurance.* These patients will pay $0 out of pocket for CRENESSITY. PANTHERx will automatically apply this program for your patients with commercial insurance.
Eligibility Criteria:
- Patient must be at least 4 years of age.
- Patient must be commercially insured and have coverage for CRENESSITY.
- Patient must have a valid prescription for CRENESSITY from a US- or US territory-licensed physician.
- Patient must currently reside in the US or a US territory.
Patient Assistance Program
We’re here to assist your patients.
9 out of 10 patients get approval through their insurance.2 For those that don't, the Patient Assistance Program (PAP) may be able to help. It is available for those who do not have insurance, whose insurance doesn’t cover CRENESSITY, or who lack the financial resources to pay for their prescription.* This program provides medication at no cost, acting as a safety net for those who may not have the means to pay for their medication.
Ensure you or your office has completed Section 3 of the Enrollment Form to the best of your ability and sign the bottom of the form. That way, your dedicated Care Coordinator can gather any remaining information and assess your patient's eligibility. Although eligibility varies, your patients can be considered for PAP regardless of their insurance type (ie, commercial, government-funded).
We’re committed to supporting you and your patients throughout this process.
QuickStart Program
Patients start treatment without delay.
Eligible patients receive a free 30-day supply of CRENESSITY to start treatment during insurance delays, with a limited number of refills available if delays continue.*
If coverage for CRENESSITY is ultimately denied, your patient may be eligible for the Patient Assistance Program.
Bridge Program
Avoid interruptions in CRENESSITY treatment.
In the event of a gap in insurance coverage, Neurocrine Access Support will help ensure there is no disruption in treatment with CRENESSITY. It’s important that you or your patients inform your Care Coordinator of any insurance updates as soon as possible.
*Additional terms and conditions apply.
Frequently Asked Questions
The cost of CRENESSITY for your patients depends on their insurance coverage.
9 out of 10 people taking CRENESSITY pay $10 or less per month for their copay. Most pay $0.1
If your patients need help to afford CRENESSITY, Neurocrine Access Support has financial support options to help them start and continue treatment.
Coverage for CRENESSITY depends on your patient’s specific insurance plan, but with the help of Neurocrine Access Support, ~9 out of 10 patients receive approval through insurance after a Prior Authorization and/or appeal, and of those approved patients, 8 out of 10 received approval within 30 days.2
If your patient’s insurance does not cover CRENESSITY, Neurocrine Access Support has financial support options to help them start and continue treatment with CRENESSITY.
Applying for financial support is straightforward.
To get started:
- Submit a completed CRENESSITY enrollment form to PANTHERx
- Include the required clinical and insurance documentation
- A Care Coordinator will assess eligibility and guide next steps
Your Care Coordinator serves as the primary point of contact throughout the process and will keep your office informed as needed.
Timing can vary depending on insurance requirements and the completeness of the submitted information.
With the help of Neurocrine Access Support, ~9 out of 10 patients receive approval through insurance after a Prior Authorization and/or appeal, and of those, 8 out of 10 received approval within 30 days.2
It is important that you provide thorough clinical information and any available lab values along with the prescription to help keep the process moving forward. Once all required documentation is received, the Care Coordinator will work with your patient’s plan and PANTHERx to keep the process moving efficiently. Prior Authorizations can take time depending on insurance requirements, but we are here to support the process and will provide updates as they become available.
We are also committed to helping patients get started and continue on CRENESSITY as the insurance process continues. Our financial support options can help patients start therapy in case of delays or gaps in insurance coverage.
Patients with Medicare or Medicaid are not eligible for the CRENESSITY Savings Program.
However, they may be evaluated for other support options, such as the Patient Assistance Program, depending on their individual situation. A Care Coordinator can help review available options and clarify next steps.
Neurocrine Access Support can help work through insurance coverage and approvals throughout your patient’s treatment journey, including with reauthorizations. Many insurance plans require proof of clinical improvement in order to approve continued use of CRENESSITY. Planning ahead to collect that information can help expedite the process. A dedicated Care Coordinator and your local Regional Patient Access Manager (RPAM) can support you and your office with the reauthorization process.
References: 1. Data on File as of May 2026. 2. Historical average analyzed May 2026.
Our commitment is simple and unwavering: to ensure every patient who needs CRENESSITY can start and continue treatment.
